View More Recent Stories

Nov 3, 2015 08:00AM Genomic Health to Present at Two Upcoming Investor Conferences
Oct 27, 2015 08:00AM Genomic Health to Announce Third Quarter 2015 Financial Results and Host Conference Call on Tuesday, November 3, 2015
Oct 15, 2015 04:30PM Medicare Initiates Coverage for Genomic Health's Oncotype DX® Prostate Cancer Test Effective Immediately
Oct 7, 2015 08:00AM CMS Increases Final Pricing Determination for Oncotype DX® Breast Cancer Test to Previously Established Rate of $3,416
Sep 28, 2015 08:00AM Genomic Health Responds to Flawed CMS Gap-fill Pricing for Oncotype DX® Breast Cancer Test
Sep 28, 2015 01:15AM TAILORx trial finds 99 percent of women with low Oncotype DX® Recurrence Score® are free of breast cancer recurrence after five years of hormone therapy alone
Sep 28, 2015 01:15AM Two Large International Studies Provide Additional Prospective Data Reinforcing the Ability of Oncotype DX® to Accurately Predict Clinical Outcomes in Early-Stage Breast Cancer Patients
Sep 11, 2015 08:00AM Multiple Oncotype DX® Outcomes Studies, Including Results from NCI-sponsored TAILORx Breast Cancer Trial, to be Presented at 2015 European Cancer Congress
Aug 17, 2015 08:00AM Genomic Health's Oncotype DX® Prostate Cancer Test Receives Medicare Coverage
Aug 4, 2015 04:07PM Genomic Health Announces Second Quarter 2015 Financial Results and Reports Record International and Prostate Cancer Tests Delivered
Jul 30, 2015 08:00AM Urology Practice Publishes Study Showing Oncotype DX® Increases Use of Active Surveillance in Prostate Cancer Patients by 56 Percent
Jul 28, 2015 08:00AM Genomic Health to Announce Second Quarter 2015 Financial Results and Host Conference Call on Tuesday, August 4, 2015
Jul 14, 2015 08:00AM Breast Cancer Research and Treatment Publishes Oncotype DX® DCIS Score™ Study
Jun 23, 2015 08:00AM Journal of Surgical Oncology Publishes Study Showing Oncotype DX® DCIS Score™ Result Changes Treatment Recommendations in 30 Percent of DCIS Breast Cancer Patients
Jun 16, 2015 08:00AM Genomic Health Presents Positive Proof-of-Concept Data for Bladder Cancer Liquid Biopsy Test
Jun 11, 2015 08:00AM Genomic Health to Present Proof-of-Concept Bladder Cancer Liquid Biopsy Data at AACR Precision Medicine Meeting
Jun 1, 2015 08:00AM Oncotype DX® Presentations at ASCO in Breast and Prostate Cancer Reinforce Genomic Health's Leadership in Optimizing Cancer Treatment
May 27, 2015 08:00AM Multiple Oncotype DX® Presentations at the American Society of Clinical Oncology Annual Meeting Highlight Genomic Health's Leadership in Personalizing Breast, Prostate Cancer Care
May 27, 2015 07:57AM Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference
May 21, 2015 08:00AM Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on Medicare Coverage for the Oncotype DX® Prostate Cancer Test
May 20, 2015 08:00AM UCSF-led Study Shows Oncotype DX® and MRI May Provide Independent Information in Favorable Risk Prostate Cancer
May 18, 2015 08:00AM Genomic Health Advances Liquid Biopsy Pipeline, Shows Ability to Accurately Monitor Urine for Presence of Bladder Cancer
May 15, 2015 08:30AM Oncotype DX® Prostate Cancer Test Improves Risk Assessment for One in Four Men and Reduces Overall Healthcare Costs
May 15, 2015 08:30AM Oncotype DX® Prostate Cancer Test Improves Risk Assessment for One in Four Men and Reduces Overall Healthcare Costs
May 11, 2015 08:00AM St. Gallen International Breast Cancer Guidelines for the Third Time Distinguish Oncotype DX® as the Only Multi-Gene Test Validated to Predict Chemotherapy Benefit
May 7, 2015 08:00AM Genomic Health to Present Multiple Oncotype DX® Studies and Positive Liquid Biopsy Results at American Urological Association Annual Meeting May 15-19
May 6, 2015 08:00AM Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference
May 5, 2015 04:01PM Genomic Health Announces First Quarter 2015 Financial Results and Reports Record Oncotype DX® Test Volume
Apr 30, 2015 08:00AM Genomic Health Announces Publication of Oncotype DX® Prostate Cancer Test Decision Impact Study in Urology Practice, Supporting Wider Adoption and Reimbursement
Apr 28, 2015 08:00AM Genomic Health to Announce First Quarter 2015 Financial Results and Host Conference Call on Tuesday, May 5, 2015
Mar 20, 2015 08:00AM Multiple Data Presentations Demonstrate Positive Direct Patient Impact of Oncotype DX® Breast Cancer Test Globally
View More Recent Stories